Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.29B | $7.01B | $8.20B | $8.23B | $8.60B | $10.9B | $12.6B | $12.6B | $15.2B | $23.1B |
| Revenue growth | — | 11.5% | 17.0% | 0.3% | 4.5% | 26.5% | 16.1% | -0.5% | 21.3% | 51.7% |
| Gross profit | $2.04B | $2.31B | $2.65B | $2.62B | $2.66B | $3.40B | $4.03B | $4.08B | $5.14B | $8.52B |
| Gross margin | 32.5% | 32.9% | 32.4% | 31.8% | 31.0% | 31.3% | 31.9% | 32.5% | 33.8% | 36.9% |
| Operating income | $1.21B | $1.43B | $1.69B | $1.62B | $1.64B | $2.11B | $2.59B | $2.56B | $3.16B | $5.87B |
| Operating margin | 19.2% | 20.4% | 20.6% | 19.7% | 19.1% | 19.4% | 20.5% | 20.4% | 20.7% | 25.4% |
| Net income | $823M | $651M | $1.21B | $1.16B | $1.20B | $1.59B | $1.90B | $1.93B | $2.42B | $4.27B |
| Net margin | 13.1% | 9.3% | 14.7% | 14.0% | 14.0% | 14.6% | 15.1% | 15.4% | 15.9% | 18.5% |
| EPS (diluted) | $2.61 | $2.06 | $3.85 | $1.88 | $1.96 | $2.54 | $1.53 | $1.55 | $1.92 | $3.34 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.08B | $1.14B | $1.11B | $1.50B | $1.59B | $1.54B | $2.17B | $2.53B | $2.81B | $5.37B |
| Capital expenditures | $191M | $227M | $311M | $295M | $277M | $360M | $384M | $373M | $665M | $997M |
| Free cash flow | $887M | $918M | $802M | $1.21B | $1.32B | $1.18B | $1.79B | $2.16B | $2.15B | $4.38B |
| Share buybacks | $326M | $618M | $935M | $602M | $641M | $662M | $731M | $585M | $689M | $665M |
| Dividends paid | $173M | $205M | $254M | $280M | $298M | $347M | $477M | $501M | $595M | $802M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.03B | $1.72B | $1.28B | $891M | $1.70B | $1.20B | $1.37B | $1.48B | $3.32B | $11.1B |
| Total assets | $8.50B | $10.0B | $10.0B | $10.8B | $12.3B | $14.7B | $15.3B | $16.5B | $21.4B | $36.2B |
| Total liabilities | — | — | — | — | $6.88B | $8.30B | $8.23B | $8.10B | $11.6B | $22.7B |
| Long-term debt | $2.64B | $3.54B | — | — | — | — | — | — | — | — |
| Shareholders' equity | $3.67B | $3.99B | $4.02B | $4.53B | $5.38B | $6.30B | $7.02B | $8.35B | $9.79B | $13.4B |
| Retained earnings | $3.12B | $2.94B | $3.03B | $3.35B | $3.71B | $4.28B | $4.98B | $5.92B | $7.11B | $9.85B |
| Shares (wtd avg diluted) | 315M | 317M | 313M | 616M | 615M | 626M | 1.24B | 1.24B | 1.26B | 1.28B |
Every figure is extracted from AMPHENOL CORP /DE/’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.